Artificial intelligence for telemedicine diabetic retinopathy screening: a review
Authors:
- Luis Filipe NakayamaLNLuis Filipe Nakayama
- Lucas Zago RibeiroLucas Zago Ribeiro
- Frederico NovaesFNFrederico Novaes
- Isabele Ayumi MiyawakiIMIsabele Ayumi Miyawaki
- Andresa Emy MiyawakiAMAndresa Emy Miyawaki
- Juliana Angélica Estevão de OliveiraJOJuliana Angélica Estevão de Oliveira
- Talita OliveiraTOTalita Oliveira
- Fernando Korn MalerbiFMFernando Korn Malerbi
- Caio Vinicius Saito RegatieriCRCaio Vinicius Saito Regatieri
- Leo Anthony CeliLCLeo Anthony Celi
- Paolo S. SilvaPSPaolo S. Silva
Open Access
- 21 September 2023
- journal article
- review article
- Published by Taylor & Francis in Annals of Medicine
- Vol. 55 (2) , 2258149
Abstract
This study aims to compare artificial intelligence (AI) systems applied in diabetic retinopathy (DR) teleophthalmology screening, currently deployed systems, fairness initiatives and the challenges for implementation. The review included articles retrieved from PubMed/Medline/EMBASE literature search strategy regarding telemedicine, DR and AI. The screening criteria included human articles in English, Portuguese or Spanish and related to telemedicine and AI for DR screening. The author’s affiliations and the study’s population income group were classified according to the World Bank Country and Lending Groups. The literature search yielded a total of 132 articles, and nine were included after full-text assessment. The selected articles were published between 2004 and 2020 and were grouped as telemedicine systems, algorithms, economic analysis and image quality assessment. Four telemedicine systems that perform a quality assessment, image preprocessing and pathological screening were reviewed. A data and post-deployment bias assessment are not performed in any of the algorithms, and none of the studies evaluate the social impact implementations. There is a lack of representativeness in the reviewed articles, with most authors and target populations from high-income countries and no low-income country representation. Telemedicine and AI hold great promise for augmenting decision-making in medical care, expanding patient access and enhancing cost-effectiveness. Economic studies and social science analysis are crucial to support the implementation of AI in teleophthalmology screening programs. Promoting fairness and generalizability in automated systems combined with telemedicine screening programs is not straightforward. Improving data representativeness, reducing biases and promoting equity in deployment and post-deployment studies are all critical steps in model development.Keywords
Funding Information
- Lemann Foundation, Instituto da Visão-IPEPO
This publication has 37 references indexed in Scilit:
- Diabetic retinopathy: global prevalence, major risk factors, screening practices and public health challenges: a reviewClinical & Experimental Ophthalmology, 2016
- Evaluation of Automated Teleretinal Screening Program for Diabetic RetinopathyJAMA Ophthalmology, 2016
- Retina image analysis and ocular telehealth: The oak ridge national laboratory-hamilton eye institute case study2013
- Evaluating predictive modeling's potential to improve teleretinal screening participation in urban safety net clinics.2013
- Global Prevalence and Major Risk Factors of Diabetic RetinopathyDiabetes Care, 2012
- Telemedicine: Opportunities and Developments in Member States: Report on the Second Global Survey on eHealth 2009 (Global Observatory for eHealth Series, Volume 2)Healthcare Informatics Research, 2012
- Publication Ethics in HIRHealthcare Informatics Research, 2012
- Cost-effectiveness of implementing automated grading within the national screening programme for diabetic retinopathy in ScotlandBritish Journal of Ophthalmology, 2007
- Quality assurance for diabetic retinopathy telescreeningDiabetic Medicine, 2005
- Telemedicine: Emerging e-medicineAnnual Review of Biomedical Engineering, 1999